US: temporary delays — postal services aligning new import rules, 
Europe: 1–2 weeks, 🌍 Worldwide: 1–4 weeks ✈️Loading...
By Rudolph
Rudolph, 2012
This book offers a detailed synopsis of the current state of diagnostics and therapeutics for Alzheimer's disease (AD). It identifies emerging technologies and molecules with promise for managing and treating AD, drawing on expertise from academia, clinical practice, and industry. The volume examines the basis of AD, the role of A' oligomers, and various diagnostic methodologies, including in vitro biomarkers and in vivo imaging. It also discusses evolving diagnostic criteria, regulatory guidelines, and recent progress in drug discovery for AD and other neurodegenerative diseases.